東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Immunopotentiators in modern vaccines

Schijns, Virgil E. J. C.

FindBook

Google Book

Amazon

博客來

Immunopotentiators in modern vaccines

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Immunopotentiators in modern vaccines/ [edited by] Virgil E.J.C. Schijns, Derek T. O'Hagan.{me_controlnum}
其他作者:	Schijns, Virgil E. J. C.
出版者:	Amsterdam ;Elsevier Academic Press, : c2006.,
面頁冊數:	xi, 371 p. :ill. ;26 cm.
內容註:	Perspective on Immunological mechanisms underlying adjuvant activity -- Host-derived immunopotentiators -- Natural and synthetic immunopotentiators -- Particulate immunopotentiators and delivery systems -- Mucosal/ non-parenteral adjuvants -- Th-1/ CTL adjuvants -- Adjuvants in non-infectious disease vaccines -- Clinical Practice.
內容註:	Unravelling "the immunologist's dirty little secret" / Virgil E.J.C. Schijns -- Dendritic cells as targets and tools in vaccines / Imerio Capone, Paola Rizza, and Filippo Belardelli -- Host-derived molecules as adjuvants / Tom Barr, Jennifer Carlring, and Andrew W. Heath -- Innate immune mechanisms and the identification of immune potentiators as vaccine adjuvants / Achal Pashine, Jeffrey B. Ulmer, and Nicholas M. Valiante -- CpG oligodeoxynucleotides as vaccine adjuvants / Michael J. McCluskie and Risini D. Weeratna -- Toll-like receptor 4 agonists as vaccine adjuvants / David H. Persing ... [et al.] -- Immunomodulatory adjuvants from Quillaja saponaria / Charlotte Read Kensil.
內容註:	Microparticles as vaccine delivery systems / Derek T. O'Hagan -- MF59: a safe and potent adjuvant for human use / Audino Podda, Giuseppe Del Giudice, and Derek T. O'Hagan -- Development and evaluation of AS04, a novel and improved adjuvant system containing MPL and aluminium salt / Nathalie Gar�con, Marcelle van Mechelen, and Martine Wettendorff -- Virosomes for vaccine delivery / Ian C. Metcalfe and Reinhard Gl�uck -- The ISCOMATRIX adjuvant / Debbie Drane and Martin J. Pearse -- Mineral adjuvants / Erik B. Lindblad.
內容註:	Mucosal adjuvants based on cholera toxin and E. coli heat-labile enterotoxin / Jan Holmgren ... [et al.] -- Transcutaneous immunization using the heat-labile enterotoxin of E. coli as an adjuvant / Richard T. Kenney and Gregory M. Glenn -- T cell adjuvants and novel strategies for their identification / Laurence Van Overvelt and Philippe Moingeon -- Vaccination to treat noninfectious diseases: surveying the opportunities / Stephen W. Martin and Martin F. Bachmann -- Clinical evaluation of adjuvants / Jakub K. Simon and Robert Edelman -- Regulatory considerations in the nonclinical safety assessment of adjuvanted preventive vaccines / Elizabeth M. Sutkowski and Marion F. Gruber.
標題:	Immunological adjuvants. -
電子資源:	http://www.sciencedirect.com/science/book/9780120884032An electronic book accessible through the World Wide Web; click for information
ISBN:	9780120884032

Immunopotentiators in modern vaccines
Immunopotentiators in modern vaccines[electronic resource] /[edited by] Virgil E.J.C. Schijns, Derek T. O'Hagan.{me_controlnum} - Amsterdam ;Elsevier Academic Press,c2006. - xi, 371 p. :ill. ;26 cm.

Includes bibliographical references and index.

Perspective on Immunological mechanisms underlying adjuvant activity -- Host-derived immunopotentiators -- Natural and synthetic immunopotentiators -- Particulate immunopotentiators and delivery systems -- Mucosal/ non-parenteral adjuvants -- Th-1/ CTL adjuvants -- Adjuvants in non-infectious disease vaccines -- Clinical Practice.

This book provides an in-depth insight and overview of a number of most promising immunopotentiators in modern vaccines. In contrast to existing books on the subject it provides recent data on the critical mechanisms governing the activity of vaccine adjuvants and delivery systems. Knowledge of immunological pathways and scenarios of the cells and molecules involved is described and depicted in comprehensive illustrations. * Contributions from leading international authorities in the field * Well-illustrated, informative figures present the interactions between immunopotentiators and the host immune system * Each chapter lists advantages and potential hurdles for achieving a practical application for the specific immunopentiator.

Electronic reproduction.
Amsterdam :
Elsevier Science & Technology,
2007.

Mode of access: World Wide Web.

ISBN: 9780120884032

Source: 108150:108193Elsevier Science & Technologyhttp://www.sciencedirect.comSubjects--Topical Terms:

1362220
Immunological adjuvants.
Index Terms--Genre/Form:

542853
Electronic books.

LC Class. No.: QR187.3 / .I56 2006eb

Dewey Class. No.: 615/.372

National Library of Medicine Call No.: 2006 B-338

Immunopotentiators in modern vaccines
LDR:04527cmm 2200385Ia 4500 001 1033042
003 OCoLC
005 20110614113922.0
006 m d
007 cr cn|||||||||
008 120420s2006 ne a ob 001 0 eng d
020 $a 9780120884032
020 $a 0120884038
029 1 $a NZ1 $b 12434808
035 $a (OCoLC)162569700
035 $a ocn162569700
037 $a 108150:108193 $b Elsevier Science & Technology $n http://www.sciencedirect.com
040 $a OPELS $b eng $c OPELS $d OCLCQ
049 $a TEFA
050 1 4 $a QR187.3 $b .I56 2006eb
060 1 4 $a 2006 B-338
060 1 4 $a QW 805 $b I337 2006
082 0 4 $a 615/.372 $2 22
245 0 0 $a Immunopotentiators in modern vaccines $h [electronic resource] / $c [edited by] Virgil E.J.C. Schijns, Derek T. O'Hagan.{me_controlnum}
260 $a Amsterdam ; $a Boston : $b Elsevier Academic Press, $c c2006.
300 $a xi, 371 p. : $b ill. ; $c 26 cm.
504 $a Includes bibliographical references and index.
505 0 $a Perspective on Immunological mechanisms underlying adjuvant activity -- Host-derived immunopotentiators -- Natural and synthetic immunopotentiators -- Particulate immunopotentiators and delivery systems -- Mucosal/ non-parenteral adjuvants -- Th-1/ CTL adjuvants -- Adjuvants in non-infectious disease vaccines -- Clinical Practice.
505 0 $a Unravelling "the immunologist's dirty little secret" / Virgil E.J.C. Schijns -- Dendritic cells as targets and tools in vaccines / Imerio Capone, Paola Rizza, and Filippo Belardelli -- Host-derived molecules as adjuvants / Tom Barr, Jennifer Carlring, and Andrew W. Heath -- Innate immune mechanisms and the identification of immune potentiators as vaccine adjuvants / Achal Pashine, Jeffrey B. Ulmer, and Nicholas M. Valiante -- CpG oligodeoxynucleotides as vaccine adjuvants / Michael J. McCluskie and Risini D. Weeratna -- Toll-like receptor 4 agonists as vaccine adjuvants / David H. Persing ... [et al.] -- Immunomodulatory adjuvants from Quillaja saponaria / Charlotte Read Kensil.
505 0 $a Microparticles as vaccine delivery systems / Derek T. O'Hagan -- MF59: a safe and potent adjuvant for human use / Audino Podda, Giuseppe Del Giudice, and Derek T. O'Hagan -- Development and evaluation of AS04, a novel and improved adjuvant system containing MPL and aluminium salt / Nathalie Gar�con, Marcelle van Mechelen, and Martine Wettendorff -- Virosomes for vaccine delivery / Ian C. Metcalfe and Reinhard Gl�uck -- The ISCOMATRIX adjuvant / Debbie Drane and Martin J. Pearse -- Mineral adjuvants / Erik B. Lindblad.
505 0 $a Mucosal adjuvants based on cholera toxin and E. coli heat-labile enterotoxin / Jan Holmgren ... [et al.] -- Transcutaneous immunization using the heat-labile enterotoxin of E. coli as an adjuvant / Richard T. Kenney and Gregory M. Glenn -- T cell adjuvants and novel strategies for their identification / Laurence Van Overvelt and Philippe Moingeon -- Vaccination to treat noninfectious diseases: surveying the opportunities / Stephen W. Martin and Martin F. Bachmann -- Clinical evaluation of adjuvants / Jakub K. Simon and Robert Edelman -- Regulatory considerations in the nonclinical safety assessment of adjuvanted preventive vaccines / Elizabeth M. Sutkowski and Marion F. Gruber.
520 $a This book provides an in-depth insight and overview of a number of most promising immunopotentiators in modern vaccines. In contrast to existing books on the subject it provides recent data on the critical mechanisms governing the activity of vaccine adjuvants and delivery systems. Knowledge of immunological pathways and scenarios of the cells and molecules involved is described and depicted in comprehensive illustrations. * Contributions from leading international authorities in the field * Well-illustrated, informative figures present the interactions between immunopotentiators and the host immune system * Each chapter lists advantages and potential hurdles for achieving a practical application for the specific immunopentiator.
533 $a Electronic reproduction. $b Amsterdam : $c Elsevier Science & Technology, $d 2007. $n Mode of access: World Wide Web. $n System requirements: Web browser. $n Title from title screen (viewed on Aug. 2, 2007). $n Access may be restricted to users at subscribing institutions.
650 0 $a Immunological adjuvants. $3 1362220
650 0 $a Immune response $x Regulation. $3 832996
650 0 $a Vaccines. $3 684854
650 1 2 $a Vaccines $x immunology. $3 1362221
650 2 2 $a Adjuvants, Immunologic. $3 1362222
650 2 2 $a Drug Delivery Systems. $3 812174
650 2 2 $a Immunotherapy. $3 597370
650 7 $a Vacinas. $2 larpcal $3 1362223
650 7 $a Adjuvantes imunol�ogicos. $2 larpcal $3 1362224
655 4 $a Electronic books. $2 lcsh $3 542853
700 1 $a Schijns, Virgil E. J. C. $3 1362218
700 1 $a O'Hagan, Derek T. $3 1362219
710 2 $a ScienceDirect (Online service) $3 848416
776 1 $c Original $z 0120884038 $z 9780120884032 $w (DLC) 2005016429 $w (OCoLC)60766955
856 4 0 $3 ScienceDirect $u http://www.sciencedirect.com/science/book/9780120884032 $z An electronic book accessible through the World Wide Web; click for information
994 $a C0 $b TEF